Activation of oncogenic signaling kinase PAK1 by ionising radiation confers an aggressive phenotype in head and neck squamous cell carcinoma
Cellular Signalling · 2023
DOI: 10.1016/j.cellsig.2023.110910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2023. Verfasst von Rohan Prasad Surabhi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Sri Ramachandra Faculty of Biomedical Sciences & Technology, Sri Ramachandra Institute of Higher Education and Research…. Hauptthemen laut MEDLINE: p21-Activated Kinases, Head and Neck Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Indian Institute of Technology Madras, Bhabha Atomic Research Centre, Department of Atomic Energy, Government of India.
Abstract (Originalsprache)
Head and neck squamous cancers are very aggressive tumors often diagnosed in late stages with poor prognosis. HNSCCs are usually treated by a course of radiation (IR) therapy and followed by surgery. These treatment regimens fail to bring a complete response. Molecular signatures in tumors are attributed to this response and an improved understanding of the signaling events could offer new avenues for therapy. Here, we show that P21 activated kinase-1 (PAK1) - an oncogenic signaling serine/threonine kinase, is activated upon exposure to IR and this leads to an accelerated tumorigenic character in HNSCC cells. Our results show that PAK1 is highly expressed in HNSCC cell lines, as compared to normal buccal mucosa cells and when HNSCC cells were exposed to IR, they show activated PAK1 and an aggressive phenotype as determined by in vitro functional assays. PAK1 levels were elevated in HNSCC as compared to adjacent normal oral tissues and our results also show convincing evidence of activated PAK1 in patient tumor samples of post- IR treatment as compared to pre-IR treatment and is associated with poor survival. Pak1 Knockout (KO) clones in HNSCC cells showed that they were more sensitive to IR as compared to wild type (wt) cells. This altered sensitivity to IR was attributed to enhanced DNA damage response modulated by PAK1 in cells. Overall, our results suggest that PAK1 expression in HNSCC could be a critical determinant in IR therapy response and silencing PAK1 is likely to be a treatment modality to improve clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Sri Ramachandra Faculty of Biomedical Sciences & Technology, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai 600116, India.
- Department of Biotechnology, Indian Institute of Technology Madras, Guindy, Chennai 600036, India.
- Department of Surgical Oncology, Sri Ramachandra Medical College, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai 600116, India.
- Department of Pathology, Sri Ramachandra Medical College, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai 600116, India.
- Department of Community Medicine, Sri Ramachandra Medical College, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai 600116, India.
- Department of Biochemistry, School of Life Sciences, University of Hyderabad, Gachibowli, Hyderabad, Telangana 500046, India.
Förderung
- Indian Institute of Technology Madras
- Bhabha Atomic Research Centre
- Department of Atomic Energy, Government of India
- Board of Research in Nuclear Sciences
Zitieren
APA
Surabhi, R. P., Rajendran, S., Srikanth Swamy Swaroop, B., Murugan, S., Shanmugasundaram, G., Joseph, L. D., Pitani, R., Babu, P. S., Suresh K, R., & Venkatraman, G. (2023). Activation of oncogenic signaling kinase PAK1 by ionising radiation confers an aggressive phenotype in head and neck squamous cell carcinoma. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2023.110910
Vancouver
Surabhi RP, Rajendran S, Srikanth Swamy Swaroop B, Murugan S, Shanmugasundaram G, Joseph LD, et al. Activation of oncogenic signaling kinase PAK1 by ionising radiation confers an aggressive phenotype in head and neck squamous cell carcinoma. Cellular Signalling. 2023. doi:10.1016/j.cellsig.2023.110910
BibTeX
@article{Surabhi2023,
author = {Surabhi, Rohan Prasad and Rajendran, Swetha and Srikanth Swamy Swaroop, B and Murugan, Sowmiya and Shanmugasundaram, Gouthaman and Joseph, Leena Dennis and Pitani, Ravishankar and Babu, Pakala Suresh and Suresh K, Rayala and Venkatraman, Ganesh},
title = {Activation of oncogenic signaling kinase PAK1 by ionising radiation confers an aggressive phenotype in head and neck squamous cell carcinoma},
journal = {Cellular Signalling},
year = {2023},
doi = {10.1016/j.cellsig.2023.110910}
}
EUVIMED